Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Biomédica (Bogotá) ; 35(2): 235-246, abr.-jun. 2015. ilus, graf, tab
Artigo em Espanhol | LILACS | ID: lil-754834

RESUMO

Introducción. La leishmaniasis es una enfermedad de gran impacto en la salud pública. La Organización Mundial de la Salud considera prioritaria la investigación orientada al desarrollo de medicamentos para su tratamiento. La exploración de la ruta del fosfatidil-inositol es interesante, ya que está implicada en la supervivencia del parásito mediante el control de la osmorregulación, el transporte a través de las membranas y la activación de diversos factores de transcripción. Objetivo. Proponer blancos para el desarrollo de medicamentos contra la leishmaniasis mediante el análisis bioinformático y el modelado matemático de esta ruta. Materiales y métodos. Se caracterizaron las proteínas pertenecientes a la ruta del fosfatidil-inositol en las bases de datos TriTrypDB y Pfam. Posteriormente, se hizo un análisis de similitud con las proteínas humanas mediante las herramientas InParanoid7 y OrthoMCL. Finalmente, se propuso un modelo booleano de la ruta, utilizando los programas PROMOT y CellNetAnalyzer. Resultados. Se reconstruyó y se describió la ruta de señalización del fosfatidil-inositol en Leishmania spp. El análisis de similitud con proteínas humanas determinó la viabilidad de las proteínas pertenecientes a la ruta del fosfatidil-inositol como potenciales blancos moleculares. Los modelos matemáticos permitieron integrar los elementos de la ruta y predecir un efecto inhibidor. Se propusieron los siguientes blancos para el desarrollo de medicamentos: inositol-3-fosfato-5-fosfatasa, fosfatidil-inositol-4-cinasa, fosfatidil-inositol-3,4,5-trisfosfato-3-fosfatasa, e inositol-polifosfato1P-fosfatasa. Conclusiones. La ruta de señalización del fosfatidil-inositol aparece como una alternativa sólida desde el punto de vista del modelo cualitativo y a partir de las proteínas encontradas. Se identificaron posibles blancos de medicamentos contra la leishmaniasis. Posteriormente, se buscarán medicamentos contra las proteínas detectadas y se hará la validación experimental.


Introduction: Leishmaniasis is a disease of high impact on public health. Research on drugs for its treatment is considered a priority by the World Health Organization. The phosphatidyl-inositol signaling pathway is interesting to explore because it is involved in the survival of the parasite, by controlling osmoregulation, transport through membranes, and activation of transcription factors. Objective: To propose drug targets against the disease through bioinformatic analysis and mathematical modeling of this signaling pathway. Materials and methods: The phosphatidyl-inositol pathway proteins were characterized through Pfam and TriTrypDB databases. Subsequently, a similarity analysis with human proteins was performed using the OrthoMCL and InParanoid7 tools. Finally, a boolean model of the pathway was proposed using PROMOT and CellNetAnalyzer softwares. Results: The phosphatidyl-inositol signaling pathway in Leishmania spp. was reconstructed and described. The similarity analysis determined the feasibility of the phosphatidyl-inositol pathway proteins as molecular targets. Mathematical models allowed integrating the elements of the path and predicted an inhibitor effect. The following were proposed as drug targets: inositol-3-phosphate-5-phosphatase, phosphatidylinositol-4-kinase, phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and Inositol-1P-polyphosphate phosphatase. Conclusion: The phosphatidyl-inositol signaling pathway is robust from the point of view of the qualitative model and the proteins found. Thus, potential drug targets against leishmaniasis were identified. Subsequently we will seek to detect drugs against this set of proteins and validate them experimentally .


Assuntos
Humanos , Biologia Computacional , Leishmania/efeitos dos fármacos , Modelos Teóricos , Fosfatidilinositóis/antagonistas & inibidores , Transdução de Sinais/efeitos dos fármacos , Leishmaniose/tratamento farmacológico , Terapia de Alvo Molecular , Fosfatidilinositóis/fisiologia
2.
Biol. Res ; 34(1): 43-50, 2001. graf, tab
Artigo em Inglês | LILACS | ID: lil-288332

RESUMO

Lemon seedlings inoculated with Alternaria alternata develop a hypersensitive response (HR) that includes the induction of Phenylalanine ammonia-lyase (PAL, E. C. 4.3.1.5) and the synthesis of scoparone. The signal transduction pathway involved in the development of this response is unknown. We used several inhibitors of the Phosphoinositide (PI) animal system to study a possible role of Inositol-1,4,5-triphosphate (IP3) in the transduction of the fungal conidia signal in Citrus limon. The HR was only partially inhibited by EGTA, suggesting that not only external but internal calcium as well are necessary for a complete development of the HR. In this plant system, Alternaria alternata induced an early accumulation of the second messenger IP3. When lemon seedlings were watered long term with LiCl, an inhibitor of the phosphoinositide cycle, the IP3 production was reduced, and the LiCl-watered plants could neither induce PAL nor synthesize scoparone in response to fungal conidia. Furthermore, neomycin, a Phospholipase C (PLC, E. C. 3.1.4.3) inhibitor, also inhibited PAL induction and scoparone synthesis in response to A. alternata. These results suggest that IP3 could be involved in the signal transduction pathway for the development of the HR of Citrus limon against A. alternata.


Assuntos
Alternaria/patogenicidade , Citrus/fisiologia , Citrus/virologia , Fosfatidilinositóis/metabolismo , Transdução de Sinais , Cafeína/farmacologia , Cálcio/farmacologia , Cumarínicos/antagonistas & inibidores , Cumarínicos/metabolismo , Fibrinolíticos/farmacologia , Heparina/farmacologia , Inositol 1,4,5-Trifosfato/fisiologia , Neomicina/farmacologia , Fenilalanina Amônia-Liase/metabolismo , Fosfatidilinositóis/antagonistas & inibidores , Inibidores de Fosfodiesterase/farmacologia , Inibidores da Síntese de Proteínas/farmacologia , Sementes
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA